Transmyocardial laser revascularization is an alternative treatment option for patients with refractory angina who are not suitable candidates for more conventional coronary intervention or surgery.

Dr. Ian Hardy, a prominent medical innovator, patented the Transmyocardial Revascularization technique in 1985 (Patent #4,658,817 Method and Apparatus for Transmyocardial Revascularization Using a ...

Specifically designed to improve blood flow in areas of the heart not treated by angioplasty or surgery, transmyocardial revascularization or TMR, uses a carbon dioxide laser to create small channels ...

Revascularization is a procedure that can restore blood flow in blocked arteries or veins. For someone with peripheral artery disease (PAD), the operation can help ease symptoms and prevent serious ...

We randomly assigned patients at increased risk for perioperative cardiac complications and clinically significant coronary artery disease to undergo either revascularization or no revascularization ...

The "US Market Report for Transmyocardial Revascularization Devices 2018 - MedCore" report has been added to Research and Markets' offering. Many patients with severe angina experience inadequate ...

NEW ORLEANS, LA—Incomplete coronary revascularization is associated with an increased risk of major adverse cardiac events, particularly an increased risk of MI, among patients who later go on to have ...

In the absence of a randomized, outcome-driven trial, coronary artery revascularization is only performed in vascular surgery patients who would benefit from coronary artery bypass grafting (CABG) ...

Patients who have noncardiac surgery within 2 years of undergoing incomplete revascularization of multivessel disease face a higher risk of MACE, especially MI, than those whose revascularization had ...

Patients are admitted to a surgical and/or cardiovascular recovery area post procedure. Standard monitoring for patients undergoing cardiac surgery is required, although the risk of many complications ...